An update on targeting Hippo-YAP signaling in liver cancer

An update on targeting Hippo-YAP signaling in liver cancer

10.1517/14728222.2012.662958

Saved in:

Bibliographic Details
Main Authors:	Liu, A.M., Xu, Z., Luk, J.M.
Other Authors:	PHARMACOLOGY
Format:	Review
Published:	2014
Subjects:	Hippo pathway Liver cancer Oncogene YAP signaling
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/108650
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Structural basis of YAP recognition by TEAD4 in the Hippo pathway
by: Chen, L., et al.
Published: (2014)

AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma
by: Xu, M.Z., et al.
Published: (2014)

IDENTIFICATION AND CHARACTERIZATION OF REGULATORY NON-CODING RNAS IN THE HIPPO-YAP/TAZ SIGNALING PATHWAY
by: ZHU BOWEN
Published: (2020)

THE INTERPLAY BETWEEN RUNX3 AND TEAD-YAP COMPLEX IN GASTRIC CANCER
by: QIAO YITING
Published: (2015)

Regulators of mammalian Hippo pathway in cancer
by: Liu, A.M., et al.
Published: (2014)

The multiple interactions of RUNX with the hippo–YAP pathway
by: Chuang, Linda Shyue Huey, et al.
Published: (2022)

BIOPHYSICAL STUDIES TO ELUCIDATE THE RECOGNITION MECHANISM OF HIPPO PATHWAY EFFECTORS YAP AND TAZ BY LATS1
by: APOORVA VERMA
Published: (2018)

MiR-520b promotes breast cancer stemness through hippo/YAP signaling pathway
by: Zhang, H., et al.
Published: (2022)

INTERPLAY BETWEEN MEVALONATE AND HIPPO PATHWAYS REGULATES DDX20 TRANSCIPTION VIA YAO-TEAD COMPLEX IN TRIPLE NEGATIVE BREAST CANCERS
by: WANG CHAO
Published: (2018)

Dropwort-induced metabolic reprogramming restrains YAP/TAZ/TEAD oncogenic axis in mesothelioma
by: Pulito, C., et al.
Published: (2021)

THE ROLE OF THE HIPPO PATHWAY IN ONCOGENIC TRANSFORMATION
by: NGUYEN THANH HUNG
Published: (2014)

Reciprocal regulation of hippo and wbp2 signalling—implications in cancer therapy
by: Lim, Yvonne Xinyi, et al.
Published: (2022)

SPATIOTEMPORAL CONTROL OF YAP LOCALISATION AND FUNCTION IN VITRO AND IN VIVO
by: TOH JIA YING PEARLYN
Published: (2023)

WBP2 PROMOTES GASTRIC CANCER CELL MIGRATION BY INHIBITING THE HIPPO SIGNALLING PATHWAY
by: MELISSA HUM WEN CHING
Published: (2018)

Loss of Yap/taz in cardiac fibroblasts attenuates adverse remodeling and improves cardiac function.
by: Mia, Masum M, et al.
Published: (2021)

WBP2 - A NOVEL TARGET OF HIPPO-INDUCED MIRNAS AND A REGULATOR OF THE MICROPROCESSOR COMPLEX IN BREAST CANCER
by: HOSSEIN TABATABAEIAN
Published: (2021)

MiR-582-5p is a tumor suppressor microRNA targeting the Hippo-YAP/TAZ signaling pathway in non-small cell lung cancer
by: Zhu, Bowen, et al.
Published: (2022)

Linking extracellular matrix agrin to the hippo pathway in liver cancer and beyond
by: Chakraborty, S, et al.
Published: (2020)

YAP/TAZ and EZH2 synergize to impair tumor suppressor activity of TGFBR2 in non-small cell lung cancer
by: Lo Sardo, Federica, et al.
Published: (2022)

The Hippo Signaling Pathway in Cardiac Development and Diseases.
by: MIA MD MASUM, et al.
Published: (2020)

Zika virus alters DNA methylation status of genes involved in Hippo signaling pathway in human neural progenitor cells.
by: Kandilya, Deepika, et al.
Published: (2019)

CHARACTERIZING THE ROLE OF FREE FATTY ACID RECEPTORS (FFARs) IN BREAST CANCER CELLS
by: MADHUMATHI THIRUNAVUKKARASAN
Published: (2017)

Emerging roles of the Hippo signaling pathway in modulating immune response and inflammation-driven tissue repair and remodeling
by: Mia, Masum M, et al.
Published: (2022)

POPX2 is a novel LATS phosphatase that regulates the Hippo pathway
by: Muhammad Bakhait Rahmat, et al.
Published: (2019)

STRUCTURAL STUDIES OF CORE KINASE CASCADE OF HIPPO SIGNALLING PATHWAY
by: ESRA BALIKCI
Published: (2021)

Targeting the Hippo signaling pathway for tissue regeneration and cancer therapy
by: Juan, W.C, et al.
Published: (2020)

Wbp2 cooperates with Yorkie to drive tissue growth downstream of the Salvador-Warts-Hippo pathway
by: Zhang, X., et al.
Published: (2014)

SKP1 promotes YAP-mediated colorectal cancer stemness via suppressing RASSF1
by: Tian, C., et al.
Published: (2021)

Common and unique transcription signatures of YAP and TAZ in gastric cancer cells
by: Lee, Y., et al.
Published: (2021)

WW domain-mediated interaction with Wbp2 is important for the oncogenic property of TAZ
by: Chan, S.W., et al.
Published: (2014)

SYSTEMATIC ANALYSIS OF TGF-ß SIGNALING AND ACTIVATION IN LIVER FIBROSIS
by: WANG JUNJIE
Published: (2013)

Agave negatively regulates YAP and TAZ transcriptionally and post-translationally in osteosarcoma cell lines
by: Ferraiuolo M., et al.
Published: (2019)

YAP/TAZ deficiency reprograms macrophage phenotype and improves infarct healing and cardiac function after myocardial infarction
by: Mia, Masum M, et al.
Published: (2021)

Study Liver Tumorigenesis in Transgenic Tumor Zebrafish using chemical screens
by: ZHOU LI
Published: (2013)

Emerging roles of TEAD transcription factors and its coactivators in cancers
by: Pobbati, A.V., et al.
Published: (2014)

BNIP-2 ACTIVATION OF FORCE DRIVES YAP CYTOSOLIC RETENTION FOR CARDIOMYOCYTE DIFFERENTIATION
by: WONG CHEN PEI DARREN
Published: (2020)

Epigenetic Small-Molecule Modulators Targeting Metabolic Pathways in Cancer
by: Das, D, et al.
Published: (2022)

Targeting YAP/TAZ-TEAD protein-protein interactions using fragment-based and computational modeling approaches
by: Kaan H.Y.K., et al.
Published: (2020)

GENOME-WIDE CRISPR SCREEN IDENTIFIES AN NF2-ADHERENS JUNCTION MECHANISTIC DEPENDENCY FOR CARDIAC LINEAGE
by: LEE CHANG JIE MICK
Published: (2022)

Targeting NF2-Hippo/Yap Signaling Pathway for Cardioprotection After Ischemia/Reperfusion Injury.
by: MIA MD MASUM, et al.
Published: (2020)